openPR Logo
Press release

Pharmacovigilance Market Report, Size, Share & Outlook - 2024-2031 - ArisGlobal, Capgemini & Cognizant.

09-09-2024 09:20 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Pharmacovigilance Market || 2024-2031

Pharmacovigilance Market || 2024-2031

The global pharmacovigilance market is projected to grow at a compound annual growth rate (CAGR) of 12.43% from 2024 to 2031.

Pharmacovigilance (PV) encompasses the science and activities involved in detecting, understanding, assessing, and preventing adverse effects or any other drug-related issues. Its primary focus is on identifying adverse drug reactions (ADRs) and drug toxicity. The pharmacovigilance market includes the reporting of all types of adverse events during clinical trials and within various healthcare settings such as hospitals and pharmacies. This process is crucial for ensuring drug safety and efficacy, aiding in the prevention of potential harm to patients through systematic monitoring and analysis of drug-related problems.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/pharmacovigilance-market

Market Trends:

The increasing trend of outsourcing pharmacovigilance services is driving the market growth.

Outsourcing pharmacovigilance is a strategic approach adopted by pharmaceutical companies to minimize fixed overhead costs and substantial upfront investments while gaining additional capacity and flexibility in resource management. This practice is particularly cost-effective for small and medium-sized enterprises. As drug consumption and development rates rise, the risk of adverse effects not detected in clinical trials increases. For example, in 2020, Fresenius Kabi USA recalled Dexmedetomidine HCL in 0.9% Sodium Chloride Injection due to cross-contamination with lidocaine, which could cause severe allergic reactions. This underscores the growing demand for thorough medical information and vigilant monitoring by regulatory authorities, driving the growth of the pharmacovigilance market.

Additionally, advancements in cancer treatments, such as targeted therapies, have introduced serious adverse effects that can impact patient quality of life. From 2014 to 2018, monoclonal antibodies were among the top ten drugs for spontaneous adverse drug reaction reports, with about 406,352 records. Emerging technologies and evolving reporting systems in pharmacovigilance further propel the market's expansion.

Market Segmentation:

By Service Provider: Contract Outsourcing, In-house.

By Type of Reporting: Intensified ADR Reporting, Spontaneous Reporting, Cohort Event Monitoring, Targeted Spontaneous Reporting, EHR Mining.

By Clinical Trial Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV.

By End-User: Hospitals, Pharmaceutical Companies.

Get Customization Report: https://www.datamintelligence.com/customize/pharmacovigilance-market

Major Players:

• ArisGlobal
• BioClinica
• Capgemini
• Cognizant
• FMD K&L Inc.
• Foresight Group International AG
• IBM Corporation
• Wipro Limited
• IQVIA

Product Portfolio:

Cognizant Technology Solutions Corp. specializes in providing information technology, consulting, and business process outsourcing services. The company operates through four primary business segments: Financial Services, Healthcare, Products and Resources, and Communications, Media, and Technology.

Regional Analysis:

The global Pharmacovigilance Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Pharmacovigilance Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

Pharmacy Automation Systems Market: https://datamintelligence.com/research-report/pharmacy-automation-systems-market

Cardiac Restoration Systems Market: https://datamintelligence.com/research-report/cardiac-restoration-systems-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance Market Report, Size, Share & Outlook - 2024-2031 - ArisGlobal, Capgemini & Cognizant. here

News-ID: 3649113 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Plant Breeding and CRISPR Plant Market Outlook 2024-2031: Innovations in Genome Editing, Crop Yield, and Sustainable Agriculture | Bayer AG, BASF, Syngenta Crop Protection AG.
United States Plant Breeding and CRISPR Plant Market Outlook 2024-2031: Innovati …
Plant Breeding and CRISPR Plant Market is forecasted to reach at a CAGR of 10.87% during the forecast period (2024-2031). This market focuses on improving crop yield, quality, and resistance through modern breeding techniques and CRISPR-based genome editing. Plant breeding innovations support food security by developing climate-resilient and pest-resistant varieties. CRISPR technology enables precise genetic modifications, reducing time compared to conventional breeding. Market growth is driven by increasing global food demand
Recent Developments in Neuromorphic Computing: Intel, IBM, Qualcomm, Fujitsu, Sony, and Global Research Institutions Driving Innovation
Recent Developments in Neuromorphic Computing: Intel, IBM, Qualcomm, Fujitsu, So …
The Global Neuromorphic Computing Market reached USD 48.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,801.9 million by 2030. The global neuromorphic computing market is expected to exhibit a CAGR of 91.5% during the forecast period (2024-2031). The neuromorphic computing market revolves around hardware and systems modeled on the human brain's neural architecture, enabling advanced processing and learning capabilities. These systems aim to
Strategic Collaborations in Electric Aircraft Charging Infrastructure: Partnerships Between Aerospace Firms, Energy Companies, and Airports | Rolls-Royce Holdings Plc, Beta Technologies, Electro.Aero Pty Ltd.
Strategic Collaborations in Electric Aircraft Charging Infrastructure: Partnersh …
Global Electric Aircraft Charging Interfaces Market reached USD 0.54 billion in 2023 and is expected to reach USD 2.1 billion by 2031 growing with a CAGR of 20.7% during the forecast period 2024-2031. This market involves charging systems and interfaces that enable electric and hybrid-electric aircraft to recharge efficiently and safely. With the aviation industry pushing toward sustainable solutions, these interfaces are critical for commercial, private, and urban air mobility vehicles.
Anti-Obesity Drugs Market Recent Developments 2025: Key Updates from the U.S., Europe, Japan, and Asia-Pacific | Major Companies are Eli Lilly and Company, Bayer AG, Bristol-Myers Squibb
Anti-Obesity Drugs Market Recent Developments 2025: Key Updates from the U.S., E …
Global Anti-Obesity Drugs Market reached US$ 2.5 billion in 2022 and is expected to reach US$ 43.7 billion by 2030 growing with a CAGR of 45.5% during the forecast period 2024-2031. The anti-obesity drugs market includes pharmaceuticals designed to promote weight loss by suppressing appetite, reducing fat absorption, or enhancing energy expenditure. Rising global obesity rates, linked to sedentary lifestyles and unhealthy diets, are driving market demand. Approved drugs include orlistat,

All 5 Releases


More Releases for Pharmacovigilance

Top Pharmacovigilance Companies Analysis By 2031
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpenPR&utm_medium=10379 The List of Companies • #Accentures • Bristol-Myers Squibb Company • Linical Accelovance • Cognizant • Covance Inc. • F. Hoffmann-La Roche Ltd. • GlaxoSmithKline plc. • ICON plc • Capgemini (IGATE Corporation) Clinical
Pharmacovigilance - Scope and Research Methodology
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The Pharmacovigilance Market report covers analysis by Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event
Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes
Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Develop …
How Are the key drivers contributing to the expansion of the pharmacovigilance market? The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches.
Monitoring Medication Safety with Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications. Download Sample PDF at: https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpnePR&utm_medium=10776 Increasing cases of adverse drug reactions
Pharmacovigilance Market Opportunity Analysis by 2028
Pharmacovigilance Market: Introduction According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before